TCT 2010 schedule: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 155: | Line 155: | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
===5:15 PM=== | |||
''5:15 PM - 5:30 PM'' | |||
*'''Interviewee:''' Dr. Gregg W. Stone | |||
*'''Trial: ''' SPIRIT IV: Two-Year Results from a Prospective Randomized Trial of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents in Patients with Coronary Artery Disease. and HORIZONS-AMI: Three-Year Follow-up from a Prospective Randomized Trial of Antithrombin Strategies and Drug-Eluting Stents in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasty | |||
*'''Embargo lift:''' 11:24 AM on Thursday September 23rd (SPIRIT IV) and 11:24 on Saturday September 25th (HORIZONS-AMI) | |||
''[[TCT 2009 schedule#Click on Date for Detailed Schedule|Return to top]]'' | ''[[TCT 2009 schedule#Click on Date for Detailed Schedule|Return to top]]'' | ||
Revision as of 13:39, 10 September 2010
Here is the page we will use to coordinate the TV events at TCT 2010. The filming will take place in our open studio on the 3rd floor of the convention center right outside the Main Arena (Ballroom A,B,C.) Open time slots are indicated below in red.
Click on Date for Detailed Schedule
Wednesday September 22, 2010
2:00 PM
2:00 PM - 2:30 PM
- Interviewee: Dr. Thomas Zeller
- Trial: DES-BTK: A Prospective, Double-Blind, Randomized Trial of Polymer-Free Sirolimus-Eluting Stents Compared to Bare Metal Stents in Patients with Infrapopliteal Disease
- Embargo lift: 12 PM on Friday September 24th
2:30 PM
2:30 PM - 3:00 PM
- Interviewee: Dr. Jean-Philippe Collet
- Trial: CLOVIS-2: A Prospective, Randomized, Nested Case-Control Crossover Study of a High vs. Low Clopidogrel Loading Dose in Clopidogrel Resistant Patients With and Without the CYP2C19*2 Loss-of-Function Allele
- Embargo lift: 7 PM on Wednesday September 22nd
3:00 PM
3:00 PM - 3:30 PM
- Interviewee: Dr. Martin Leon
- Trial: PARTNER: A Prospective Randomized Trial of Transcatheter Aortic Valve Implantation Compared to Standard Therapy in Patients with Inoperable Aortic Stenosis
- Embargo lift: 11 AM on Thursday September 23rd
3:30 PM
OPEN TIME SLOT
4:00 PM
4:00 PM - 4:30 PM
- Interviewee: Dr. Gennaro Sardella
- Trial: ROMA: A Prospective Randomized Trial of Rosuvastatin Pretreatment Prior to Percutaneous Coronary Intervention
- Embargo lift: 7:45 PM on Tuesday Sepetember 21st
4:30 PM
OPEN TIME SLOT
5:00 PM
5:00 PM - 5:30 PM
- Interviewee: Dr. Bernard R. Chevalier
- Trial: CRISTAL: A Prospective Randomized Trial of Sirolimus-Eluting Stents Compared to Balloon Angioplasty for Restenosis of Drug-Eluting Coronary Stents
- Embargo lift: 11:42 AM on Saturday September 25th
Thursday September 23, 2010
9:45 AM
OPEN TIME SLOT
10:15 AM
OPEN TIME SLOT
10:45 AM
OPEN TIME SLOT
11:15 AM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
1:20 PM
OPEN TIME SLOT
3:30 PM
OPEN TIME SLOT
3:50 PM
OPEN TIME SLOT
Friday September 24, 2010
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
2:00 PM - 2:30 PM
- Interviewee: Dr. Julinda Mehilli
- Trial: ISAR-TEST-5: A Prospective Randomized Trial of Polymer-Free Sirolimus-/Probucol-Eluting Stents Compared to Zotarolimus-Eluting Stents in Patients with Coronary Artery Disease
- Embargo lift: 11:00 AM on Saturday September 25th
2:30 PM
OPEN TIME SLOT
3:00 PM
3:00 PM - 3:30 PM
- Interviewee: Dr. Robert A. Byrne
- Trial: ISAR-TEST-4: Two-Year Clinical and Angiographic Outcomes from a Prospective Randomized Trial of Everolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease
- Embargo lift: 11:42 AM on Friday September 24th
3:30 PM
3:30 PM - 4:00 PM
- Interviewee: Dr. Mohsen Sharifi
- Trial: TORPEDO: A Prospective Randomized Trial of Percutaneous Endovenous Intervention Compared to Anticoagulation Alone in Patients with Deep Venous Thrombosis
- Embargo lift: 12:15 PM on Friday September 24th
4:00 PM
4:00 PM - 4:30 PM
- Interviewee: Dr. Michelle O'Donoghue
- Trial: LANCELOT ACS: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of a Reversible PAR-1 Thrombin Receptor Antagonist in Patients with Acute Coronary Syndromes
- Embargo lift: 12:00 PM on Thursday September 23rd
4:30 PM
OPEN TIME SLOT
5:00 PM
OPEN TIME SLOT
Saturday September 25, 2010
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
12:00 PM
OPEN TIME SLOT
12:30 PM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
4:00 PM
OPEN TIME SLOT
4:30 PM
OPEN TIME SLOT
5:15 PM
5:15 PM - 5:30 PM
- Interviewee: Dr. Gregg W. Stone
- Trial: SPIRIT IV: Two-Year Results from a Prospective Randomized Trial of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents in Patients with Coronary Artery Disease. and HORIZONS-AMI: Three-Year Follow-up from a Prospective Randomized Trial of Antithrombin Strategies and Drug-Eluting Stents in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasty
- Embargo lift: 11:24 AM on Thursday September 23rd (SPIRIT IV) and 11:24 on Saturday September 25th (HORIZONS-AMI)